The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

8 Jul 2019 07:00

RNS Number : 7136E
Science Group PLC
08 July 2019
 

 

8 July 2019

Science Group plc

(the "Company")

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

Science Group plc (AIM:SAG) welcomes the Frontier announcement issued on Friday 5 July regarding the clarification of the Frontier statement issued on 14 June 2019. Science Group concludes that:

· Science Group's Offer is the only offer for Frontier - as announced on 1 July and posted to Frontier Shareholders on 2 July 2019;

· Contrary to previous indications by Frontier (14 June) regarding the alternative approach, it is now "unlikely that the discussions will result in an offer for" Frontier from this alternative source;

· Frontier's discussions regarding a further alternative new proposal from the same party are at no more than a "concept" stage, after 3 weeks of "urgently seeking to clarify" this alternative approach. The basic transaction framework has not even been agreed and "there is no meaningful prospect of agreeing Heads of Terms, less still entering into a definitive legal agreement, prior to the closing date of the Science Group Offer of 16 July 2019". This indicates that the "potential, but uncertain" discussions are preliminary and speculative; and

· Frontier's operating performance and expectations for the current year remain unchanged following the significant downgrade it announced on 9 May 2019, which resulted in Frontier's share price falling to a closing price of 13.4 pence.

 

In summary, despite the substantial premium being offered by Science Group relative to the share price on the date of the trading update, the Frontier Board are advising Frontier Shareholders to reject the Science Group Offer on the basis that at some undefined point in the future, Frontier may possibly agree a joint venture with an undefined party into which Frontier would transfer key assets. The structure and terms of this hypothetical activity are currently unknown to the Frontier Board and the potential value to be created and how any such value would be realised for Frontier Shareholders is completely unclear. Furthermore, even if this "potential, but uncertain, prospect" did develop, the Frontier Board may or may not grant Frontier Shareholders the opportunity to vote on this transfer of assets and the terms of any transaction.

 

Throughout the past 8 weeks, in the opinion of Science Group, Frontier has repeatedly taken actions which have had the effect of frustrating the proposed acquisition of Frontier by Science Group. This latest "concept" of a non-specific strategy being proposed by the Frontier Board can only be regarded similarly. It should be remembered that, at 31 December 2018, Frontier had net retained losses of $175.5 million resulting from Frontier's previous strategies and that between January 2018 and 9 May 2019, the current Frontier Board pursued a strategy that resulted in a share price decline of over 90%.

 

At the close of trading on 5 July 2019, Science Group held 11,879,601 shares, equivalent to 29.2% of the voting share capital of Frontier. Science Group reiterates its previous statements that it does not anticipate supporting any alternative "potential corporate transaction".

 

Science Group does not anticipate increasing the Offer price and reminds Frontier Shareholders that the Offer of 35 pence per share, represents:

· a 161.6% premium to the closing share price on 9 May 2019, the date of the Frontier trading update; and

· a 137.3% premium to the share price on 17 May 2019, the last trading day prior to the announcement of Science Group's approach.

 

Science Group also reminds Frontier Shareholders that the closing date for the Science Group Offer is Tuesday 16 July 2019. At the present time, and taking into account the Frontier announcement issued on 5 July, Science Group does not anticipate extending the Offer, nor the Panmure Gordon Trading Facility, but retains the option to do so if considered appropriate at the sole discretion of the Science Group Board

 

In conclusion, Science Group encourages Frontier Shareholders to accept the Science Group Offer, or sell their shares through the Panmure Gordon Trading Facility, as soon as possible and in any event prior to the closing date of Tuesday 16 July 2019.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina

(Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

MHP Communications (PR Adviser to Science Group)

Reg Hoare / Pete Lambie

 

Tel: +44 (0) 20 3128 8100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBRGDRSGGBGCR
Date   Source Headline
26th Jun 20077:00 amPRNFinal Results
29th May 20077:00 amPRNProduct Collaboration
3rd May 20077:00 amPRNFuture Waves Design Win
20th Apr 20074:48 pmRNSHolding(s) in Company
23rd Mar 20075:04 pmRNSHolding(s) in Company
14th Mar 20074:36 pmRNSExercise of Options
26th Feb 20077:00 amPRNKey Development Milestone
21st Dec 200612:20 pmRNSResult of EGM
19th Dec 20067:02 amRNSToumaz Wins Oracle Award
5th Dec 20065:18 pmRNSNotice of EGM
22nd Nov 20065:41 pmRNSExercise of Options
3rd Nov 200611:55 amRNSExercise of Options
26th Oct 20064:09 pmRNSExercise of Options
13th Oct 20067:00 amPRNToumaz Debuts New Sensium(TM) Module
10th Oct 20063:58 pmRNSDirector/PDMR Shareholding
7th Sep 20065:12 pmPRNResult of AGM
7th Sep 20067:00 amPRNAppointment of CEO
6th Sep 20067:00 amPRNAGM Statement
23rd Aug 20067:00 amPRNStrategic Investment
18th Aug 20064:01 pmRNSHolding(s) in Company
3rd Jul 20067:00 amPRNDirectorate Change
30th Jun 20067:02 amRNSInterim Results
28th Apr 20067:00 amPRNFinal Results
21st Apr 20067:00 amPRNToumaz Appoints New CEO
13th Feb 200611:23 amRNSHolding(s) in Company
23rd Dec 20057:00 amPRNUpdate
11th Nov 20051:40 pmRNSHolding(s) in Company
9th Nov 20056:08 pmRNSHolding(s) in Company
7th Nov 200510:36 amRNSHolding(s) in Company
2nd Nov 20052:49 pmPRNResult of EGM
19th Oct 20051:35 pmRNSSchedule 1 - Nanoscience Inc
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
21st Sep 20052:22 pmPRNInterim Results
31st Aug 200510:56 amPRNStrategic Investment
9th Jun 200510:00 amRNSRe Investment
3rd May 200512:17 pmRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.